The field of andrology has undergone substantial transformation due to advancements in diagnostic technologies. Traditional evaluation methods such as physical examination and basic erotic semen analysis remain essential; however, modern diagnostic tools now allow for more precise and comprehensive assessment of male reproductive function.
Semen analysis, standardized by the World Health Organization, continues to serve as the primary screening tool for male fertility. Yet, it provides limited insight into sperm functional competence. To address these limitations, advanced tests such as sperm DNA fragmentation analysis, oxidative stress assays, and computer-assisted semen analysis (CASA) systems have been introduced.
Hormonal profiling has also evolved, incorporating sensitive assays for total testosterone, free testosterone, sex hormone-binding globulin (SHBG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin. Imaging modalities such as high-resolution scrotal ultrasound and magnetic resonance imaging (MRI) assist in detecting structural abnormalities, including varicocele, tumors, and obstructive lesions.
Genetic testing represents another breakthrough in diagnostic andrology. Karyotyping and Y-chromosome microdeletion analysis provide critical information in cases of severe oligospermia or azoospermia. These advancements facilitate personalized treatment strategies and more accurate prognostic counseling.
The integration of laboratory innovation and imaging technology has significantly improved diagnostic precision, enabling clinicians to tailor therapeutic interventions more effectively.
Leave a Reply